Arimura A, et al. Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury. Blood. Jan 2006; 107(2):661-668.
Kinhult J, et al. The induction of carbon monoxide-mediated airway relaxation by PACAP 38 in isolated guinea pig airways. Lung. 2001; 179(1):1-8.
PACAP 38 is a neuropeptide that has substantial sequence homology to vasoactive intestinal peptide (VIP). Both VIP and PACAP 38 are equipotent at the VCAP-2 receptor, while PACAP 38 is equipotent to PACAP-27 and more potent than VIP at the PAC-1 receptor. Pituitary adenylate cyclase activating polypeptide (PACAP) 38 stimulates the release of LH from superfused pituitary cells and that the hypothalamus and anterior pituitary have highly selective binding sites for the peptide.
Formula
C204H333N63O53S1
M.W.
4548.4
Cas
137061-48-4
Purity
> 95%
Storage
Store at -20°C.
* For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.